Climb Bio, Inc. · NASDAQ:CLYM
Ra Capital Management, L.P. reported a 33.00% stake in Climb Bio, Inc. (Schedule 13D/A)
Event Apr 27, 2026 · Filed Apr 29, 2026
Ra Capital Management, L.P. reported a 33.00% stake in Climb Bio, Inc., 22,631,401 shares, with active intent on Apr 27, 2026. Filed Apr 29, 2026 (Schedule 13D/A).
- Stake
- 33.00%
- Shares
- 22,631,401
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 33.00% | 22,631,401 |
| Peter Kolchinsky | 33.00% | 22,631,401 |
| Rajeev Shah | 33.00% | 22,631,401 |
| RA Capital Healthcare Fund, L.P. | 25.00% | 17,123,763 |
| RA Capital Nexus Fund III, L.P. | 9.30% | 5,346,247 |
| Sera Medicines, LLC | 4.30% | 2,479,872 |
Source
Related
- Climb Bio, Inc.
- Ra Capital Management, L.P.
- Climb Bio, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 7, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Dec 15, 2025
- Form 4 · RA Capital Nexus Fund, L.P. · Sep 30, 2026
- Form 4 · Thomas Stephen Basil · Sep 17, 2026
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G · FMR LLC · Jul 8, 2026
- Form 4 · Brennan Aoife · Jun 30, 2026